Objective: The objective of this study was to evaluate the serum concentration of transforming growth factor-β1 (TGF-β1) after low-level laser therapy (LLLT) in patients with hypothyroidism resulting from chronic autoimmune thyroiditis (CAT). Background data: Certain data indicate that LLLT is effective in patients with hypothyroidism caused by CAT; however, the mechanisms of action of LLLT in thyroid tissue are unknown. Cytokines could play a role in the response to LLLT. Methods: A randomized, placebo-controlled trial included 43 patients with a history of levothyroxine therapy for CAT-induced hypothyroidism. The patients were randomly assigned to receive either 10 sessions of LLLT (830 nm, 50 mW output power, and 707 J/cm2 fluence; L group, n=23) or 10 sessions of a placebo treatment (P group, n=20) twice a week. Levothyroxine was maintained at the same dose during the entire study period. TGF-β1 was measured both pre-intervention and 30 days post-intervention in both groups. The differences were calculated between the TGF-β1 values observed 30 days post-intervention and the pre-intervention TGF-β1 values for each group (intragroup). Results: Comparing the differences in TGF-β1 levels between the L group (874.9±541.7 pg/mL) and the P group (−128.4±832.8 pg/mL) revealed that there was a statistically significant increase in TGF-β1 levels 30 days post-intervention in group L compared with the placebo group (p=0.0379). Conclusions: This finding suggested that the significant increase in serum TGF-β1 levels in patients with CAT-induced hypothyroidism was associated with the thyroid LLLT procedure. Future studies of the effect of LLLT on TGF-β1 gene expression in thyroid tissue are necessary to confirm these findings.
Get full access to this article
View all access options for this article.
References
1.
DayanC.M., and DanielsG.H. (1996). Chronic autoimmune thyroiditis. N. Engl. J. Med., 335, 99–107.
2.
FountoulakisS., and TsatsoulisA. (2004). On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis. Clin. Endocrinol. (Oxf ), 60, 397–409.
3.
KaranikasG., SchuetzM., WahlK., Paul, et al. (2005). Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis. Clin. Endocrinol. (Oxf ), 63, 191–196.
4.
LiuC., PapewalisC., DombergJ., ScherbaumW.A., and SchottM. (2008). Chemokines and autoimmune thyroid diseases. Horm. Metab. Res., 40, 361–368.
5.
GaneshB.B., BhattacharyaP., GopisettyA., and PrabhakarB.S. (2011). Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. J. Interferon Cytokine Res, 31, 721–731.
6.
KongY.C., MorrisG.P., BrownN.K., YanY., FlynnJ.C., and DavidC.S. (2009). Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function. J. Autoimmun., 33, 239–246.
7.
ManganP.R., HarringtonL.E., O'QuinnD.B., et al. (2006). Transforming growth factor-beta induces development of the T(H)17 lineage. Nature, 441, 231–234.
8.
AkinciB., ComlekciA., YenerS., et al. (2008). Hashimoto's thyroiditis, but not treatment of hypothyroidism, is associated with altered TGF-beta1 levels. Arch. Med. Res., 39, 397–401.
9.
Prud'hommeG.J., and PiccirilloC.A. (2000). The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J. Autoimmun., 14, 23–42.
10.
GaoX., and XingD. (2009). Molecular mechanisms of cell proliferation induced by low power laser irradiation. J. Biomed. Sci., 16, 4.
11.
VuralP., DegirmenciogluS., ErdenS., and GelincikA. (2009). The relationship between transforming growth factor-beta1, vascular endothelial growth factor, nitric oxide and Hashimoto's thyroiditis. Int. immunopharmacol., 9, 212–215.
12.
SafaviS.M., KazemiB., EsmaeiliM., FallahA., ModarresiA., and MirM. (2008). Effects of low-level He-Ne laser irradiation on the gene expression of IL-1beta, TNF-alpha, IFN-gamma, TGF-beta, bFGF, and PDGF in rat's gingiva. Lasers Med. Sci., 23, 331–335.
13.
HoflingD.B., ChavantesM.C., JulianoA.G., et al. (2010). Low-level laser therapy in chronic autoimmune thyroiditis: a pilot study. Lasers Surg. Med., 42, 589–596.
14.
HoflingD.B., ChavantesM.C., JulianoA.G., et al. (2012). Low-level laser in the treatment of patients with hypothyroidism induced by chronic autoimmune thyroiditis: a randomized, placebo-controlled clinical trial. Lasers Med. Sci., 28, 743–753.
15.
HoflingD.B., ChavantesM.C., JulianoA.G., et al. (2012). Assessment of the effects of low-level laser therapy on the thyroid vascularization of patients with autoimmune hypothyroidism by color Doppler ultrasound. ISRN Endocrinol., 2012, 126720.
16.
DuarteG.C., TomimoriE.K., CamargoR.Y., et al. (2009). The prevalence of thyroid dysfunction in elderly cardiology patients with mild excessive iodine intake in the urban area of Sao Paulo. Clinics (Sao Paulo), 64, 135–142.
17.
RobertsC.G., and LadensonP.W. (2004). Hypothyroidism. Lancet, 363, 793–803.
18.
BjordalJ.M., Lopes–MartinsR.A., and IversenV.V. (2006). A randomised, placebo controlled trial of low level laser therapy for activated Achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrations. Br. J. Sports Med., 40, 76–80.
19.
BjordalJ.M., Lopes–MartinsR.A., JoensenJ., et al. (2008). A systematic review with procedural assessments and meta-analysis of low level laser therapy in lateral elbow tendinopathy (tennis elbow). BMC Musculoskelet. Disord., 9, 75.
20.
AlvesA.C., de CarvalhoP.T., ParenteM., et al. (2013). Low-level laser therapy in different stages of rheumatoid arthritis: a histological study. Lasers Med. Sci., 28, 529–536.
21.
YamauraM., YaoM., YaroslavskyI., CohenR., SmotrichM., and KochevarI.E. (2009). Low level light effects on inflammatory cytokine production by rheumatoid arthritis synoviocytes. Lasers Surg. Med., 41, 282–290.
22.
BoschiE.S., LeiteC.E., SaciuraV.C., et al. (2008). Anti-Inflammatory effects of low-level laser therapy (660 nm) in the early phase in carrageenan-induced pleurisy in rat. Lasers Surg. Med., 40, 500–508.
23.
WangS.H., ChenG.H., FanY., Van AntwerpM., and BakerJ.R.Jr. (2009). Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells. Endocrinology, 150, 2000–2007.
24.
LeungM.C., LoS.C., SiuF.K., and SoK.F. (2002). Treatment of experimentally induced transient cerebral ischemia with low energy laser inhibits nitric oxide synthase activity and up-regulates the expression of transforming growth factor-beta 1. Lasers Surg. Med., 31, 283–288.
25.
AranyP.R., NayakR.S., HallikerimathS., LimayeA.M., KaleA.D., and KondaiahP. (2007). Activation of latent TGF-beta1 by low-power laser in vitro correlates with increased TGF-beta1 levels in laser-enhanced oral wound healing. Wound Repair Regen., 15, 866–874.
26.
YuS., FangY., SharpG.C., and Braley–MullenH. (2010). Transgenic expression of TGF-beta on thyrocytes inhibits development of spontaneous autoimmune thyroiditis and increases regulatory T cells in thyroids of NOD.H-2h4 mice. J. Immunol., 184, 5352–5359.
27.
PyoS.J., SongW.W., KimI.R., et al. (2013). Low-level laser therapy induces the expressions of BMP-2, osteocalcin, and TGF-beta1 in hypoxic-cultured human osteoblasts. Lasers Med. Sci., 28, 543–550.
28.
DangY., LiuB., LiuL., et al. (2011). The 800-nm diode laser irradiation induces skin collagen synthesis by stimulating TGF-beta/Smad signaling pathway. Lasers Med. Sci., 26, 837–843.
29.
TodaS., NishimuraT., YamadaS., et al. (1999). Immunohistochemical expression of growth factors in subacute thyroiditis and their effects on thyroid folliculogenesis and angiogenesis in collagen gel matrix culture. J. Pathol., 188, 415–422.
